Since the function of the hypothalamic-pituitary-adrenal (HPA) axis is known to be dysregulated in patients with AD and/or depression [35,36], we evaluated whether GR signaling is affected by tau in in vitro and in vivo experiments. The gene discussed is MAPT; the disease is Alzheimer disease.